(Q36958256)

17 August 2017

1 reference

title

Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity (English)

1 reference

17 August 2017

0 references

1 reference

7

Nicole Gallo-Payet

1 reference

17 August 2017

5

Jean-Luc Ardilouze

0 references

Jean-Patrice Baillargeon

4

object named as

Jean-Patrice Baillargeon

1 reference

17 August 2017

Marie-France Langlois

3

object named as

Marie-France Langlois

1 reference

17 August 2017

2

André C Carpentier

1 reference

17 August 2017

Claude Roberge

1

1 reference

17 August 2017

Jean-Luc Ardilouze

5

1 reference

17 August 2017

Pierre Maheux

6

1 reference

17 August 2017

language of work or name

1 reference

2 October 2007

1 reference

American Journal of Physiology - Endocrinology and Metabolism

17 August 2017

1 reference

17 August 2017

293

1 reference

17 August 2017

6

1 reference

17 August 2017

E1465-78

1 reference

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

17 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Genetics of Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Actions of PPARgamma agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Do stress reactions cause abdominal obesity and comorbidities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Local androgen inactivation in abdominal visceral adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Gender-specific response to interstitial angiotensin II in human white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

An oxidized metabolite of linoleic acid stimulates corticosterone production by rat adrenal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

An oxidized derivative of linoleic acid stimulates dehydroepiandrosterone production by human adrenal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The control by angiotensin II of cholesterol supply for aldosterone biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Pharmacological characterization of angiotensin II binding sites in the canine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Studies on the physiological functions of the melanocortin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The effect of aldosterone on glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Metabolic syndrome and cardiometabolic risk in PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Chronic stress and obesity: a new view of "comfort food"

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Be fit or be sick: peroxisome proliferator-activated receptors are down the road

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Sustained inhibitory effect of Agouti Related Protein on the ACTH-induced cortisol production by bovine cultured adrenal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Human adipocytes secrete mineralocorticoid-releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The adipocyte: storage depot or node on the energy information superhighway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Obesity wars: molecular progress confronts an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The renin-angiotensin-aldosterone system, glucose metabolism and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Aldosterone--a hormone of cardiovascular adaptation and maladaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Overexpression of Agrt leads to obesity in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

On the role of liver X receptors in lipid accumulation in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II, PPAR-gamma and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Stress, visceral obesity, and metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Is dehydroepiandrosterone a hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Fat tissue metabolism and adrenal steroid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Free fatty acids increase androgen precursors in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Production of angiotensin II receptors type one (AT1) and type two (AT2) during the differentiation of 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Short- and long-term effects of ACTH on the adrenal zona glomerulosa of the rat. A coupled stereological and enzymological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Gonadal and adrenal androgen secretion in hirsute females

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Changes in the expression of steroid metabolism-related genes in rat adrenal glands during selective REM sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II and aldosterone regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The growth-promoting effects of angiotensin II in adrenal glomerulosa cells: an interactive tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Obesity and androgens: facts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Expression of the glucocorticoid receptor in the human adrenal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Targeting the liver in the metabolic syndrome: evidence from animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Genetic and nutrient determinants of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Ovarian and adrenal steroid production: regulatory role of LH/HCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Sleep and vascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Adrenocortical cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Obesity and cortisol status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Expression of angiotensin II receptors type 1 and type 2 in human preadipose cells during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Mechanisms of glucocorticoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The critical role of the melanocortin system in the control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin blockade prevents type 2 diabetes by formation of fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Mineralocorticoid hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Increased ACTH and corticosterone secretion induced by different methods of paradoxical sleep deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Enhanced 11beta-hydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Epidemiology: testosterone and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

A possible involvement of melanocortin 3 receptor in the regulation of adrenal gland function in the chicken

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Obesity, hypertension, and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

The effects of angiotensin-II on lipolysis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Direct inhibitory effects of leptin on the neonatal adrenal and potential consequences for brain glucocorticoid feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin AT2 receptors: cardiovascular hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Aldosterone and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Prevention of adipose tissue depletion during food deprivation in angiotensin type 2 receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Liver X receptors as integrators of metabolic and inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00516.2007

10.1152/AJPENDO.00516.2007

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference